EE670 Management Costs of Grade 3/4 Adverse Events Associated with Emerging and Existing Systemic Therapies for Metastatic Colorectal Cancer with at Least Two Prior Lines of Therapy in Italy, Portugal, Spain, and the United States

V. Paly, L.G. Hernandez, A. Howe, P. Khanduri, P. Labisa, A. Taglioni, L. Siviero,A. Dasari, C. Eng,J. Hubbard, T. Bekaii-Saab, A. Sobrero,E. Elez

Value in Health（2023）

引用 0|浏览1